TY - JOUR
T1 - Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016
T2 - Five years of experience with an internal registry
AU - Jimenez, Adriana
AU - Trepka, Mary Jo
AU - Munoz-Price, L. Silvia
AU - Pekovic, Vukosava
AU - Ibrahimou, Boubakari
AU - Abbo, Lilian M.
AU - Martinez, Octavio
AU - Sposato, Kathleen
AU - dePascale, Dennise
AU - Perez-Cardona, Armando
AU - McElheny, Christi L.
AU - Bachman, William C.
AU - Fowler, Erin L.
AU - Doi, Yohei
AU - Fennie, Kristopher
N1 - Publisher Copyright:
© 2020 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2020/11
Y1 - 2020/11
N2 - Background: Carbapenem-resistant Enterobacteriaceae (CRE) is an urgent public health threat globally. Limited data are available regarding the epidemiology of CRE in South Florida. We describe the epidemiology of CRE within a large public healthcare system in Miami, FL, the experience with an internal registry, active surveillance testing, and the impact of infection prevention practices. Methods: Retrospective cohort study in 4 hospitals from a large healthcare system in Miami-Dade County, FL from 2012 to 2016. The internal registry included all CRE cases from active surveillance testing from rectal and/or tracheal screening occurring in the intensive care units of 2 of the hospitals and clinical cultures across the healthcare system. All CRE cases were tagged in the electronic medical record and automatically entered into a platform for automatic infection control surveillance. The system alerted about new cases, readmissions, and transfers. Results: A total of 371 CRE cases were identified. The overall prevalence was 0.077 cases per 100 patient-admissions; the admission prevalence was 0.019 per 100 patient-admissions, and the incidence density was 1.46 cases per 10,000 patient-days. Rates increased during the first 3 years of the study and declined later to a lower level than at the beginning of study period. Conclusions: Active surveillance testing and the use of an internal registry facilitated prompt identification of cases contributing to control increasing rates of CRE by rapid implementation of infection prevention strategies.
AB - Background: Carbapenem-resistant Enterobacteriaceae (CRE) is an urgent public health threat globally. Limited data are available regarding the epidemiology of CRE in South Florida. We describe the epidemiology of CRE within a large public healthcare system in Miami, FL, the experience with an internal registry, active surveillance testing, and the impact of infection prevention practices. Methods: Retrospective cohort study in 4 hospitals from a large healthcare system in Miami-Dade County, FL from 2012 to 2016. The internal registry included all CRE cases from active surveillance testing from rectal and/or tracheal screening occurring in the intensive care units of 2 of the hospitals and clinical cultures across the healthcare system. All CRE cases were tagged in the electronic medical record and automatically entered into a platform for automatic infection control surveillance. The system alerted about new cases, readmissions, and transfers. Results: A total of 371 CRE cases were identified. The overall prevalence was 0.077 cases per 100 patient-admissions; the admission prevalence was 0.019 per 100 patient-admissions, and the incidence density was 1.46 cases per 10,000 patient-days. Rates increased during the first 3 years of the study and declined later to a lower level than at the beginning of study period. Conclusions: Active surveillance testing and the use of an internal registry facilitated prompt identification of cases contributing to control increasing rates of CRE by rapid implementation of infection prevention strategies.
UR - http://www.scopus.com/inward/record.url?scp=85084508183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084508183&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2020.04.013
DO - 10.1016/j.ajic.2020.04.013
M3 - Article
C2 - 32334004
AN - SCOPUS:85084508183
SN - 0196-6553
VL - 48
SP - 1341
EP - 1347
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 11
ER -